Header links
Intranet
Donate now
image/svg+xml Map
Contact us

M Mar Mañu Pereira

M Mar Mañu Pereira

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
M Mar Mañu Pereira
LinkedIn

M Mar Mañu Pereira

M Mar Mañu Pereira
LinkedIn

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Head of research Lab in rare anemia disorders at VHIR - 2018 - Currently
Institut de Recerca contra la Leucèmia Josep Carreras - 2016-2018
Institut d'Investigacions Biomèdiques August Pi i Sunyer / Hospital Clínic de Barcelona - 2002-2016
Dr in BioMedicine 2009

Projects

GENOMED4ALL - Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, GENOMED4ALL - Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases, Ferran Balbastre Ubeda, Amira Idrizovic, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 434000
Reference: GENOMED4ALL_H2020-SC1-FA-DTS-2018-20
Duration: 01/01/2021 - 31/12/2024

Erythrocytes properties and viability in dependence of flow and extra-cellular environment (EVIDENCE)

IP: M Mar Mañu Pereira
Collaborators: Amira Idrizovic
Funding agency: EUROPEAN COMMISSION
Funding: 250904.88
Reference: EVIDENCE_H2020_MSCA-ITN2019
Duration: 01/01/2020 - 31/12/2023

European Rare Blood Disorders Platform - ENROL

IP: M Mar Mañu Pereira
Collaborators: European Rare Blood Disorders Platform - ENROL
Funding agency: EUROPEAN COMMISSION
Funding: 93954.6
Reference: ENROL_HP-PJ-01-2019
Duration: 01/06/2020 - 31/05/2023

European Reference Network on Rare Hematological Diseases [ERN-EuroBloodNet] [739541] - Framework Partnership Agreement

IP: M Mar Mañu Pereira
Collaborators: Victoria Gutierrez Valle, Reidel , Sara Isabel, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 545439.59
Reference: EUROBLOODNET_FPA-ERN3HP2016
Duration: 01/03/2018 - 30/04/2022

Related news

Entrega xec Mi compañero de viaje

Mi Compañero de Viaje adds a decade of donations in the fight against cancer

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

Equip del grup de Càncer i Malalties Hematològiques Infantils del VHIR

A study demonstrates the effectiveness of gene therapy in patients with Fanconi anemia

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

RECLIP

Vall d'Hebron hosts RECLIP meeting, the network of paediatric clinical trials in Spain

During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.

See more

Related professionals

Carlota Zabaco Lanfranco

Carlota Zabaco Lanfranco

Administration and Management
Research on Aging, Frailty and Transitions in Barcelona
Read more
Luisa Maria Martinez Sánchez

Luisa Maria Martinez Sánchez

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Maria Emilia Dip Pérez

Maria Emilia Dip Pérez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Marta Sese Faustino

Marta Sese Faustino

Postdoctoral researcher
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.